Franklin Resources Inc Eye Point Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

$378 Billion
Q3 2025

A detailed history of Franklin Resources Inc transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 4,171,884 shares of EYPT stock, worth $49.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,171,884

Previous 4,301,123 3.0%

Holding current value

$49.4 Million

Previous $40.5 Million 42.66%

% of portfolio

0.02%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$9.01 - $14.19 $1.16 Million - $1.83 Million	-129,239 Reduced 3.0%	4,171,884 $57.7 Million
Q2 2025 Aug 12, 2025	BUY	$4.13 - $10.54 $624,712 - $1.59 Million	151,262 Added 3.64%	4,301,123 $40.5 Million
Q1 2025 May 13, 2025	BUY	$5.42 - $9.22 $66,633 - $113,350	12,294 Added 0.3%	4,149,861 $22.5 Million
Q4 2024 Feb 12, 2025	BUY	$7.02 - $12.12 $881,143 - $1.52 Million	125,519 Added 3.13%	4,137,567 $30.8 Million
Q3 2024 Nov 12, 2024	BUY	$7.58 - $10.54 $2.75 Million - $3.82 Million	362,399 Added 9.93%	4,012,048 $32.1 Million
Q2 2024 Aug 14, 2024	BUY	$8.16 - $22.89 $2.12 Million - $5.96 Million	260,412 Added 7.68%	3,649,649 $31.8 Million
Q1 2024 May 13, 2024	SELL	$19.93 - $29.71 $24.9 Million - $37.2 Million	-1,251,414 Reduced 26.97%	3,389,237 $70.1 Million
Q4 2023 Feb 09, 2024	BUY	$5.71 - $24.13 $2.79 Million - $11.8 Million	488,206 Added 11.76%	4,640,651 $107 Million
Q3 2023 Nov 13, 2023	SELL	$7.99 - $15.36 $7.29 Million - $14 Million	-912,138 Reduced 18.01%	4,152,445 $33.2 Million
Q2 2023 Aug 11, 2023	SELL	$3.03 - $9.0 $2.16 Million - $6.42 Million	-713,557 Reduced 12.35%	5,064,583 $44.1 Million
Q1 2023 May 12, 2023	BUY	$2.28 - $5.04 $8,278 - $18,300	3,631 Added 0.06%	5,778,140 $17 Million
Q4 2022 Feb 10, 2023	BUY	$2.37 - $7.2 $390,177 - $1.19 Million	164,632 Added 2.93%	5,774,509 $20.2 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $1.11 Million - $1.78 Million	159,624 Added 2.93%	5,609,877 $44.4 Million
Q2 2022 Aug 11, 2022	BUY	$7.25 - $12.71 $945,581 - $1.66 Million	130,425 Added 2.45%	5,450,253 $42.9 Million
Q1 2022 May 13, 2022	BUY	$8.67 - $14.11 $3.23 Million - $5.26 Million	372,663 Added 7.53%	5,319,828 $64.6 Million
Q4 2021 Feb 11, 2022	BUY	$10.18 - $18.4 $18 Million - $32.6 Million	1,772,828 Added 55.85%	4,947,165 $60.6 Million
Q3 2021 Nov 12, 2021	BUY	$7.51 - $11.72 $2.84 Million - $4.43 Million	377,664 Added 13.5%	3,174,337 $33.1 Million
Q2 2021 Aug 13, 2021	SELL	$8.69 - $11.08 $795,778 - $1.01 Million	-91,574 Reduced 3.17%	2,796,673 $25.1 Million
Q1 2021 May 13, 2021	BUY	$8.89 - $14.92 $13.1 Million - $22 Million	1,474,300 Added 104.27%	2,888,247 $29.3 Million
Q4 2020 Feb 10, 2021	BUY	$3.7 - $6.58 $5.23 Million - $9.3 Million	1,413,947 New	1,413,947 $9.3 Million

Others Institutions Holding EYPT

# of Institutions

168

Shares Held

68M

Call Options Held

454K

Put Options Held

401K

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $404M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Eye Point Pharmaceuticals, Inc. Transaction History